- Home
- MAIA vs ONCY Comparison
MAIA vs ONCY Comparison
Compare MAIA & ONCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MAIA
- ONCY
- Stock Information
- Founded
- MAIA 2018
- ONCY 1998
- Country
- MAIA United States
- ONCY Canada
- Employees
- MAIA N/A
- ONCY N/A
- Industry
- MAIA Biotechnology: Pharmaceutical Preparations
- ONCY Pharmaceuticals and Biotechnology
- Sector
- MAIA Health Care
- ONCY Health Care
- Exchange
- MAIA Nasdaq
- ONCY Nasdaq
- Market Cap
- MAIA 62.4M
- ONCY 103.8M
- IPO Year
- MAIA 2022
- ONCY 1999
- Fundamental
- Price
- MAIA $2.82
- ONCY $1.19
- Analyst Decision
- MAIA
- ONCY Strong Buy
- Analyst Count
- MAIA 0
- ONCY 2
- Target Price
- MAIA N/A
- ONCY $4.00
- AVG Volume (30 Days)
- MAIA 60.0K
- ONCY 903.7K
- Earning Date
- MAIA 11-05-2024
- ONCY 11-05-2024
- Dividend Yield
- MAIA N/A
- ONCY N/A
- EPS Growth
- MAIA N/A
- ONCY N/A
- EPS
- MAIA N/A
- ONCY N/A
- Revenue
- MAIA N/A
- ONCY N/A
- Revenue This Year
- MAIA N/A
- ONCY N/A
- Revenue Next Year
- MAIA N/A
- ONCY N/A
- P/E Ratio
- MAIA N/A
- ONCY N/A
- Revenue Growth
- MAIA N/A
- ONCY N/A
- 52 Week Low
- MAIA $0.82
- ONCY $0.84
- 52 Week High
- MAIA $5.99
- ONCY $1.80
- Technical
- Relative Strength Index (RSI)
- MAIA 50.98
- ONCY 52.51
- Support Level
- MAIA $2.36
- ONCY $1.17
- Resistance Level
- MAIA $2.72
- ONCY $1.28
- Average True Range (ATR)
- MAIA 0.22
- ONCY 0.09
- MACD
- MAIA 0.02
- ONCY -0.01
- Stochastic Oscillator
- MAIA 72.28
- ONCY 28.00
About MAIA MAIA Biotechnology Inc.
MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company. The company develops targeted immunotherapies for cancer. The company is an immune-oncology company, focused on the development of first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer. The company's program is THIO, a potential cancer telomere-targeting agent in clinical development for the treatment of telomerase-positive cancer cells.
About ONCY Oncolytics Biotech Inc.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatment. The other projects in the company's pipeline include, Bracelet-1 for treatment of Breast Cancer, Goblet cohort-1, Goblet cohort-5 for treatment of Gastro-Intestinal Cancer among others.